akhatri

MHRA Class 2 Medicines Notification: Mercaptopurine 50mg Tablets (Aspen Pharma Trading Limited) Drug alert number: EL(25)A/23 Date issued: 22 May 2025 Aspen Pharma Trading Limited is recalling a specific batch of Mercaptopurine 50mg tablets as a precautionary measure due to microbial contamination following a small number of complaints of discoloured tablets within the packs, identified [...]

The post MHRA Class 2 Medicines Recall: Mercaptopurine 50mg Tablets (Aspen Pharma Trading Limited) appeared first on Community Pharmacy England.

Pharmacy teams should be aware that the brand Nystan® 100,000units/ml oral suspension (ready mixed) (Vygoris Ltd) 30 ml has been discontinued and is no longer available for community pharmacies to order. Zydus Pharmaceuticals UK Ltd has introduced a generic version of Nystatin 100,000units/ml oral suspension, which is available to order from wholesalers. Please note, where [...]

The post Discontinuation of Nystan® 100,000units/ml oral suspension (ready mixed) (Vygoris Ltd) appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: BD ChloraPrep Clear – 1mL Applicator (Becton Dickinson UK Ltd) Drug alert number: EL(25)A/22 Date issued: 19 May 2025 Becton Dickinson UK Ltd has informed the MHRA that some units exhibit an open seal on the packaging of the applicator. This defect could increase the risk of the applicator device [...]

The post MHRA Class 2 Medicines Recall: BD ChloraPrep Clear – 1mL Applicator (Becton Dickinson UK Ltd) appeared first on Community Pharmacy England.

Pharmacy teams can help to raise awareness by displaying posters in their pharmacy to remind patients about the savings they can make with prepayment certificates (PPCs). PPCs offer savings for those needing multiple prescription items or when a patient is prescribed a listed HRT medicine. The cost of each type of PPC has been frozen for [...]

The post Promoting NHS prescription prepayment certificates appeared first on Community Pharmacy England.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the risk of psychological side effects while taking Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor). Psychological side effects such as anxiety, low mood, sleep disturbance, poor concentration, and forgetfulness have been infrequently reported in people with cystic fibrosis treated with Kaftrio. Healthcare professionals should advise patients [...]

The post MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects appeared first on Community Pharmacy England.